Global Cancer Drugs Market Size & Share Will Grow USD

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
87
Global Cancer Drugs Market Size & Share Will Grow USD 161.30 Billion by 2021: Zion Market Research

Sarasota, FL, July 03, 2017 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled “Cancer Drugs Market by Therapy (Immunotherapy, Targeted Therapy, Chemotherapy, Hormone Therapy and Others) for Breast Cancer, Blood Cancer, Gastrointestinal Cancer, Prostate Cancer, Skin Cancer, Lung Cancer and Other Cancer: Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 - 2021” . According to the report, global  cancer drugs market  was valued at approximately USD 112.90 billion in 2015 and is expected to generate revenue of around USD 161.30 billion by end of 2021, growing at a CAGR of around 7.4% between 2016 and 2021. 

Cancer is defined as a disease which occurs as a result of changes in a group of normal cells within the body which leads to uncontrolled growth resulting in the formation of lump called a tumor; (except for cancer of the blood). If left untreated, tumors can grow and spread into the surrounding normal tissue, or to other parts of the body via lymphatic systems and the bloodstream, and can in turn severely impact the functioning of the digestive, nervous and circulatory systems.

Browse through 27 Market Tables and 25 Figures spread through 110 Pages and in-depth TOC on “Global Cancer Drugs Market: Type, Size, Share, Trends, Review, Analysis, Segment and Forecast 2015-2021”.

Request Free Sample copy of Global Cancer Drugs Market Report @ https://www.zionmarketresearch.com/sample/can...ugs-market

Global cancer drugs market is primarily driven by growing incidences of target disease such as lung cancer, breast cancer, cervical cancer, etc. across the globe. Other major driving factors are increasing research and development on biological and targeted drug therapies for the treatment of cancer coupled along with the expiration of patents. However, the high price of drug development and stringent regulatory policies coupled along with the possibility of failure are the major restraints that may limit the growth of the market. Nonetheless increasing focus on personalized medicine coupled along with huge investment in anti-cancer drugs research across the globe is likely to disclose the new avenues for cancer drugs market in the near future.

The cancer drugs market is segmented on the basis of the different therapeutic segment including immunotherapy, targeted therapy, chemotherapy, hormone therapy and others. Immunotherapy segment is expected to grow at fastest rate in the global market over the forecast period.

Browse the full " Cancer Drugs Market by Therapy (Immunotherapy, Targeted Therapy, Chemotherapy, Hormone Therapy and Others) for Breast Cancer, Blood Cancer, Gastrointestinal Cancer, Prostate Cancer, Skin Cancer, Lung Cancer and Other Cancer: Global Industry Perspective, Comprehensive Analysis, and Forecast, 2015 - 2021 " report at  https://www.zionmarketresearch.com/report/can...ugs-market

Breast cancer, blood cancer, gastrointestinal cancer, prostate cancer, skin cancer, lung cancer and others are the key cancer types of the global cancer drugs market. The blood cancer segment dominated the market in terms of revenue. 

North America, Europe, Asia-Pacific, Latin America and the Middle East & Africa are key regional segments of global cancer drugs market. North America is anticipated to remain the leading region over the forecast period in 2015. Demand for cancer drugs was highest in North America especially in the U.S. Hence, Asia Pacific is expected to be the moderate growing region in cancer drugs market during the forecast period. Moreover, the Middle East and Africa and Latin America are also expected to show moderate growth for this market in the years to come.

Inquire more about this report before purchase @ https://www.zionmarketresearch.com/inquiry/ca...ugs-market

Some of the key players in cancer drugs market include Bayer, GlaxoSmithKline, Novartis, Sanofi and Pfizer, Amgen, Merck, Bristol-Myers Squibb, Celgene Corporation, Ariad Pharmaceuticals, Eli Lilly, Hoffmann-La Roche Ltd, Boehringer Ingelheim GmbH, Johnson and Johnson and Teva Pharmaceuticals among others.

Request customized copy of report @ https://www.zionmarketresearch.com/custom/490

This report segments the global cancer drugs market as follows: Global Cancer Drugs Market: Therapy Segment Analysis

  • Immunotherapy
  • Targeted Therapy
  • Chemotherapy
  • Hormone Therapy
  • Others

Global Cancer Drugs Market: Application Segment Analysis.

  • Breast Cancer
  • Blood Cancer
  • Gastrointestinal Cancer
  • Prostate Cancer
  • Skin Cancer
  • Lung Cancer
  • Others

Global Cancer Drugs Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

Related Reports:

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Follow Us LinkedIn: https://www.linkedin.com/company/zion-market-research

Follow Us Twitter: https://twitter.com/zion_research

Contact Us: Joel John 4283, Express Lane, Suite 634-143, Sarasota, Florida 34249, United States Tel: +49-322 210 92714 USA/Canada Toll-Free No.1-855-465-4651 Email: sales@zionmarketresearch.com Website: https://www.zionmarketresearch.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Brands Must Choose: Cost or Value Leadership?

Updated Category News Views 6

Navigating the Business Jungle: Strategic Choices Unveiled If you've ever found yourself tangled in a web of corporate doublespeak, then you'll nod along with this: all those lofty brand management strategies often boil down to a fight over dollars or dizzying customer satisfaction. What's the winning play? According to Info-Tech Research Group, it's about firmly standing...

Continue Reading
Subaru, Motorq Offer Hardware-Free Fleet Telematics Insights

Updated Category News Views 6

An Unplugged Move in Fleet Management There's something brewing between Motorq and Subaru that could shake up fleet operations in ways most haven't thought possible yet. We’re talking about cutting those pesky hardware cords and diving straight into a future that's software-driven—and hey, we're all here for it. Direct, Data-Driven Leadership Imagine you're a fleet...

Continue Reading
Rise Treatment Center Launches in Vegas for Teens

Updated Category News Views 6

Las Vegas Debuts Rise Adolescent Treatment Center Imagine being a parent in Las Vegas, staring at the daunting task of finding genuine help for your teenage kid just entering those rebellious years. The choices usually feel sparse and lacking. But on August 13, 2026, a shimmer of hope illuminated the landscape with the opening of Rise Adolescent Treatment Center. It’s a...

Continue Reading
CATL Opens Europe's Largest Battery Service Hub

Updated Category News Views 6

A New Era for EV Batteries in Norway Stepping into Oslo's tech realm, CATL's grand opening is not just another corporate ribbon-cutting spree. It's a big splash in Europe's battery pool, boasting the largest NING SERVICE center outside of Asia. Here we are, folks, at the crossroads where the EV market meets the nitty-gritty of practical service. Norway's Electric...

Continue Reading
Starr Conspiracy Unveils AI Tool for B2B Tech Firms

Updated Category News Views 6

AI-Driven Insight in Minutes: A Game Changer for B2B Hold onto your hats, because The Starr Conspiracy just lit a fire in the B2B tech world with its latest offering—Battle Card Builder. This free tool cranks out competitive intelligence in no time, literally about four minutes. Geared specifically for B2B tech marketing and sales teams, it combines decades of know-how...

Continue Reading
Unicycive's Legal Turmoil: Opportunity for Investor Action

Updated Category News Views 5

Unicycive's Legal Headache: What's Brewing? Here we go again, folks. If you're holding shares of Unicycive Therapeutics, Inc. (UNCY), buckle up because it's looking like a storm's on the horizon. The Law Offices of Howard G. Smith have dropped the news that shareholders can step up to lead a securities fraud class action lawsuit against the company. That chance to be part...

Continue Reading
New Podcast by Paralyzed Veterans of America Offers Unique Insights

Updated Category News Views 6

Empowering Veterans Through Storytelling Some stories don't just rattle around in your headphones—they stick with you. The 'Voices of PVA' podcast, launched by Paralyzed Veterans of America, aims to do exactly that. It's not just a podcast; it's a platform where voices of veterans and people with spinal cord injuries like MS and ALS aren't just heard, they're amplified....

Continue Reading
Dr. David Lifschutz Honored for Psychiatry Innovation

Updated Category News Views 7

Recognizing a Legacy in Mental Wellness Under the glare of recognition's spotlight, Dr. David H. Lifschutz steps into an exclusive circle of elite professionals. He's been acknowledged as a Pinnacle Lifetime Member by The Inner Circle for his remarkable contributions to psychiatry and mental health care. This ain't just any pat on the back. It's a badge of honor stitched...

Continue Reading
Lincoln Educational Services Faces Securities Fraud Suit

Updated Category News Views 4

A Storm Brews Over Lincoln Educational Services You know, there's nothing quite like the stink of a good mess in the markets, and Lincoln Educational Services Corporation has found itself knee-deep in one. The buzz is all about some securities fraud allegations that could rope in a bunch of investors who got the short end of the stick. It’s lawsuits like these that make...

Continue Reading
illycaffè's B Corp™ Recertification Reflects Bold Commitment

Updated Category News Views 6

illycaffè Hits Milestone with B Corp™ Recertification In an era where corporate responsibility isn't just fodder for feel-good presentations, illycaffè has proven it’s not just paying lip service to the idea. The Italian coffee titan has secured its B Corp™ recertification under snazzier, sharper V2 standards. This isn't just a shiny sticker to slap on marketing...

Continue Reading

Top 5 Most Recently Viewed Articles

ProLogium Advances Green Energy with New Gigafactory Permits

Updated Category News Views 323

ProLogium Receives Key Permits for its New Gigafactory ProLogium, recognized as a leader in next-generation lithium ceramic batteries, proudly announces that its Gigafactory in Dunkirk has received critical construction and environmental permits. This significant achievement emphasizes the company's unwavering commitment to promoting clean energy solutions. A Milestone in...

Continue Reading
Zynex Investors Alert: Class Action Lawsuit Opportunity Ahead

Updated Category News Views 98

Zynex, Inc. Investors Should Take Note of Legal Developments Attention investors of Zynex, Inc. (NASDAQ: ZYXI); there is significant news concerning a class action lawsuit that is currently underway. Bronstein, Gewirtz & Grossman, LLC is leading the charge to notify all affected investors about their potential rights in this matter. If you have incurred losses due to your...

Continue Reading
Understanding Your Rights as an Orthofix Investor Amid Lawsuits

Updated Category News Views 89

Overview of the Class Action Lawsuit Against Orthofix Medical Inc. If you’re an investor in Orthofix Medical Inc. (NASDAQ: OFIX), it's important to know about an ongoing class action lawsuit that could affect your investments. The Gross Law Firm has issued a reminder to shareholders that timing is crucial, especially with a deadline for lead plaintiffs coming up. For...

Continue Reading
Explore Nosferatu: The Immersive Horror Experience Soon!

Updated Category News Views 340

Unveiling Nosferatu: The Immersive Experience Cineverse (NASDAQ: CNVS), a rising star in the entertainment industry, is poised to unveil a captivating event that horror enthusiasts won't want to miss. In partnership with Bloody Disgusting, Focus Features, and Thirteenth Floor Entertainment, they announce the eagerly awaited Nosferatu: The Immersive Experience, inspired by...

Continue Reading
Unlocking Potential: Curql Accelerate's Impactful Fintech Program

Updated Category News Views 263

Curql Accelerate: A Unique Opportunity for Fintech Founders Curql Collective is thrilled to announce the opening of applications for its third Curql Accelerate cohort. This initiative is designed specifically for early-stage fintech founders eager to gain invaluable insights, funding, and connections within the credit union industry. Collaborating with Gener8tor, a...

Continue Reading